Chimaera™ is a point-of-care system based on selective filtration of peripheral blood to obtain autologous mononuclear cells (monocytes and lymphocytes).
The technology filters blood through gravity, avoiding any action that could alter or stress cells (e.g. centrifugation). The core of the system is a membrane that can select cells by dimensional filtration, thus eliminating all the inflammatory cells such as granulocytes.